Related references
Note: Only part of the references are listed.Dosimetry for Lu-177-DKFZ-PSMA-617: a new radiopharmaceutical for the treatment of metastatic prostate cancer
Andreas Delker et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2016)
68Ga-PSMA-11 PET/CT: a new technique with high potential for the radiotherapeutic management of prostate cancer patients
Florian Sterzing et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2016)
Imaging quality of 44Sc in comparison with five other PET radionuclides using Derenzo phantoms and preclinical PET
Maruta Bunka et al.
APPLIED RADIATION AND ISOTOPES (2016)
Standardisation and precise determination of the half-life of 44Sc
E. Garcia-Torano et al.
APPLIED RADIATION AND ISOTOPES (2016)
New Strategies in Prostate Cancer: Prostate-Specific Membrane Antigen (PSMA) Ligands for Diagnosis and Therapy
Uwe Haberkorn et al.
CLINICAL CANCER RESEARCH (2016)
Radioligand Therapy With 177Lu-PSMA-617 as A Novel Therapeutic Option in Patients With Metastatic Castration Resistant Prostate Cancer
Kambiz Rahbar et al.
CLINICAL NUCLEAR MEDICINE (2016)
18F-Labelled PSMA-1007 shows similarity in structure, biodistribution and tumour uptake to the theragnostic compound PSMA-617
Frederik L. Giesel et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2016)
Radiation dosimetry of 68Ga-PSMA-11 (HBED-CC) and preliminary evaluation of optimal imaging timing
Ali Afshar-Oromieh et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2016)
Clinical translation of 177Lu-labeled PSMA-617: Initial experience in prostate cancer patients
Tapas Das et al.
NUCLEAR MEDICINE AND BIOLOGY (2016)
44Sc for labeling of DOTA- and NODAGA-functionalized peptides: preclinical in vitro and in vivo investigations
Katharina A. Domnanich et al.
EJNMMI RADIOPHARMACY AND CHEMISTRY (2016)
Synthesis and Evaluation of GdIII-Based Magnetic Resonance Contrast Agents for Molecular Imaging of Prostate-Specific Membrane Antigen
Sangeeta Ray Banerjee et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2015)
Cancer Statistics, 2015
Rebecca L. Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2015)
The Theranostic PSMA Ligand PSMA-617 in the Diagnosis of Prostate Cancer by PET/CT: Biodistribution in Humans, Radiation Dosimetry, and First Evaluation of Tumor Lesions
Ali Afshar-Oromieh et al.
JOURNAL OF NUCLEAR MEDICINE (2015)
Evaluation of Hybrid 68Ga-PSMA Ligand PET/CT in 248 Patients with Biochemical Recurrence After Radical Prostatectomy
Matthias Eiber et al.
JOURNAL OF NUCLEAR MEDICINE (2015)
Preclinical Evaluation of a Tailor-Made DOTA-Conjugated PSMA Inhibitor with Optimized Linker Moiety for Imaging and Endoradiotherapy of Prostate Cancer
Martina Benesova et al.
JOURNAL OF NUCLEAR MEDICINE (2015)
Comparison of [18F]DCFPyL and [68Ga]Ga-PSMA-HBED-CC for PSMA-PET Imaging in Patients with Relapsed Prostate Cancer
Markus Dietlein et al.
MOLECULAR IMAGING AND BIOLOGY (2015)
Initial Evaluation of [F-18]DCFPyL for Prostate-Specific Membrane Antigen (PSMA)-Targeted PET Imaging of Prostate Cancer
Zsolt Szabo et al.
MOLECULAR IMAGING AND BIOLOGY (2015)
Cyclotron production of 44Sc: From bench to bedside
Nicholas P. van der Meulen et al.
NUCLEAR MEDICINE AND BIOLOGY (2015)
Early side effects and first results of radioligand therapy with 177Lu-DKFZ-617 PSMA of castrate-resistant metastatic prostate cancer: a two-centre study
Hojjat Ahmadzadehfar et al.
EJNMMI RESEARCH (2015)
The diagnostic value of PET/CT imaging with the 68Ga-labelled PSMA ligand HBED-CC in the diagnosis of recurrent prostate cancer
Ali Afshar-Oromieh et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2015)
64Cu-Labeled Inhibitors of Prostate-Specific Membrane Antigen for PET Imaging of Prostate Cancer
Sangeeta Ray Banerjee et al.
JOURNAL OF MEDICINAL CHEMISTRY (2014)
Novel Preclinical and Radiopharmaceutical Aspects of [68Ga]Ga-PSMA-HBED-CC: A New PET Tracer for Imaging of Prostate Cancer
Matthias Eder et al.
PHARMACEUTICALS (2014)
Promises of Cyclotron-Produced 44Sc as a Diagnostic Match for Trivalent β--Emitters: In Vitro and In Vivo Study of a 44Sc-DOTA-Folate Conjugate
Cristina Mueller et al.
JOURNAL OF NUCLEAR MEDICINE (2013)
Imaging of prostate cancer with PET/CT and radioactively labeled choline derivates
Bernd Joachim Krause et al.
UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS (2013)
68Ga-Complex Lipophilicity and the Targeting Property of a Urea-Based PSMA Inhibitor for PET Imaging
Matthias Eder et al.
BIOCONJUGATE CHEMISTRY (2012)
Comparison of sequential planar 177Lu-DOTA-TATE dosimetry scans with 68Ga-DOTA-TATE PET/CT images in patients with metastasized neuroendocrine tumours undergoing peptide receptor radionuclide therapy
Aurora Sainz-Esteban et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2012)
Scandium-44: Benefits of a Long-Lived PET Radionuclide Available from the (44) Ti/(44) Sc Generator System
F. Roesch
CURRENT RADIOPHARMACEUTICALS (2012)
Modern Detection of Prostate Cancer's Bone Metastasis: Is the Bone Scan Era Over?
Bertrand Tombal et al.
ADVANCES IN UROLOGY (2012)
Macrocyclic complexes of scandium radionuclides as precursors for diagnostic and therapeutic radiopharmaceuticals
A. Majkowska-Pilip et al.
JOURNAL OF INORGANIC BIOCHEMISTRY (2011)
68Ga-Labeled Inhibitors of Prostate-Specific Membrane Antigen (PSMA) for Imaging Prostate Cancer
Sangeeta Ray Banerjee et al.
JOURNAL OF MEDICINAL CHEMISTRY (2010)
Preclinical Evaluation of Novel Glutamate-Urea-Lysine Analogues That Target Prostate-Specific Membrane Antigen as Molecular Imaging Pharmaceuticals for Prostate Cancer
Shawn M. Hillier et al.
CANCER RESEARCH (2009)
Evaluation of a novel radiofolate in tumour-bearing mice: promising prospects for folate-based radionuclide therapy
Cristina Mueller et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2009)
Imaging techniques for prostate cancer: implications for focal therapy
Baris Turkbey et al.
NATURE REVIEWS UROLOGY (2009)
Radiolabeled small-molecule ligands for prostate-specific membrane antigen:: In vivo imaging in experimental models of prostate cancer
CA Foss et al.
CLINICAL CANCER RESEARCH (2005)
Trends in prostate cancer mortality among black men and white men in the United States
KC Chu et al.
CANCER (2003)
Share Paper
